Back to Search
FELICIA LUCAS, MD
MD
Family Medicine Physician
NPI: 1093128076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
M-15258(ID)67042(MT)MD61593047(WA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Brood size modifications affect plumage bacterial assemblages of European starlings.
PMID 15660952·Mol Ecol·2005
4-observational
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.
PMID 19656678·Bioorg Med Chem Lett·2009
7-preclinical
Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach.
PMID 19523822·Bioorg Med Chem Lett·2009
8-other
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
PMID 19520573·Bioorg Med Chem Lett·2009
7-preclinical
Development and calibration of a portable radon sampling system for groundwater 222Rn activity concentration measurements.
PMID 19608307·J Environ Radioact·2009
8-other
Therapy related CMML: a case report and review of the literature.
PMID 19430863·Int J Hematol·2009
5-case
Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).
PMID 19348415·J Med Chem·2009
8-other
Molecular evaluation of the incidence of Ehrlichia canis, Anaplasma platys and Babesia spp. in dogs from Ribeirão Preto, Brazil.
PMID 17920967·Vet J·2009
7-preclinical
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.
PMID 19347608·Fam Cancer·2009
8-other
Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration.
PMID 19195882·Bioorg Med Chem Lett·2009
4-observational
Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension.
PMID 19091748·J Biol Chem·2009
7-preclinical
The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
PMID 19498103·J Pharmacol Exp Ther·2009
7-preclinical
Intracellular nitric oxide assessment in whole blood leukocytes by flow cytometry: optimization and applicability to monitor patients with chronic graft nephropathy.
PMID 19374002·J Immunol Methods·2009
8-other
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
PMID 18577731·JAMA·2008
4-observational
Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
PMID 18854538·JAMA·2008
8-other
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer.
PMID 18237408·BMC Cancer·2008
4-observational
Changes in the use of carotid revascularization among the medicare population.
PMID 18283142·Arch Surg·2008
8-other
Characterization of a prospective human model for study of the reproductive hormone responses to major illness.
PMID 18413673·Am J Physiol Endocrinol Metab·2008
8-other
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors.
PMID 18539455·Bioorg Med Chem Lett·2008
7-preclinical
Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era.
PMID 19064681·Circulation·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 6615 COMANCHE STREET
BONNERS FERRY, ID 83805 - Phone
- (208) 267-1718
Quick Facts
- NPI
- 1093128076
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile